Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 26, 2023
October 25, 2023
b3f969a3-6d17-4b51-aee6-e6cb19f8e4ba
Related Documents
Drug Master Files Guidance for Industry
Guidance DocumentNovember 15, 2019Center for Drug Evaluation and Research
Inspection of Injectable Products for Visible Particulates: Draft Guidance for Industry
Guidance DocumentDecember 16, 2021Center for Drug Evaluation and Research
Postapproval Changes to Drug Substances Guidance for Industry
Guidance DocumentSeptember 11, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox